CELLSCRIPT专注于再生医学,细胞再生学以及细胞疗法。细胞、组织或器官的移植治疗及修复中应用的细胞或生物体。CellScript还生产用于传递和翻译的合成修饰mRNA。
The mission of CELLSCRIPT™ is to provide the best products and technologies for making and using RNA for translation in cells for clinical research and therapeutics.
Current products include kits forin vitro transcription, 5' RNA capping using either a cap analog or capping enzymes, and 3' RNA polyadenylation, as well as all-in-one kits for making capped, poly(A)-tailed mRNA for translation in cells.
产品列表:
CELLSCRIPT |
A-Plus™ Poly(A) Polymerase Tailing Kit |
50 rxns |
C-PAP5104H |
CELLSCRIPT |
AmpliCap-Max™ T7 High Yield Message Maker Kit |
25 rxns |
C-ACM04037 |
CELLSCRIPT |
AmpliCap™ SP6 High Yield Message Maker Kit |
25 rxns |
C-AC0706 |
CELLSCRIPT |
Anti-Reverse Cap Analog (ARCA) |
500 nmol |
C-C50110 |
CELLSCRIPT |
Cap-Clip™ Acid Pyrophosphatase |
100 units |
C-CC15011H |
CELLSCRIPT |
INCOGNITO™ SP6 Ψ-RNA Transcription Kit |
10 rxns |
C-ICSY110510 |
CELLSCRIPT |
INCOGNITO™ T7 ARCA 5mC- & |
10 rxns |
C-ICTAMY110510 |
CELLSCRIPT |
INCOGNITO™ T7 5mC- & |
10 rxns |
C-ICTMY110510 |
CELLSCRIPT |
INCOGNITO™ T7 Ψ-RNA Transcription Kit |
10 rxns |
C-ICTY110510 |
CELLSCRIPT |
MessageMAX™ T7 ARCA-Capped Message Transcription Kit |
10 rxns |
C-MMA60710 |
CELLSCRIPT |
Monomethylated RNA Cap Analog |
1,250 nmol |
C-C61025 |
CELLSCRIPT |
PseudoU-RNA Molecular Weight Markers |
25 lanes |
C-PRM101125 |
CELLSCRIPT |
ScriptCap™ 2'-O-Methyltransferase Kit |
10 rxns |
C-SCMT0610 |
25 rxns |
C-SCMT0625 |
||
CELLSCRIPT |
ScriptCap™ m7G Capping System |
10 rxns |
C-SCCE0610 |
25 rxns |
C-SCCE0625 |
||
CELLSCRIPT |
ScriptGuard™ RNase Inhibitor |
2,500 units |
C-SRI6325 |
10,000 units |
C-SRI6310K |
||
CELLSCRIPT |
SP6-Scribe™ Standard RNA IVT Kit |
50 rxns |
C-AS3106 |
CELLSCRIPT |
T7 mScript™ Standard mRNA Production System |
10 rxns |
C-MSC11610 |
25 rxns |
C-MSC100625 |
||
CELLSCRIPT |
T7-Scribe™ Standard RNA IVT Kit |
25 rxns |
C-AS2607 |
50 rxns |
C-AS3107 |
苏州蚂蚁淘生物科技有限公司成立于2017年,致力于将全球领先的创新产品和前沿技术带入中国,帮助国内科研工作者在第一时间接触世界范围内的技术革命,并分享研发工具的进步带来的技术红利。依托于集团公司深厚的资源和超过400家的国内优质客户群体,生命科学领域的一站式供应链体系,以及高风险生物危险材料进出口平台的优势,蚂蚁淘生物严格筛选国际创新且经过同行验证过的产品和技术,引入中国市场,开发、孵育和推广。公司的未来将立足于实验室大数据整合和电子商务,结合严格的品牌筛选、创新的营销模式、专注的应用支持和坚实服务,帮助实现生命科学产业链的简单和高效。